Overall, patients with a prior diagnosis of HF had lower LVEF and higher plasma NTproBNP, and were more frequently treated with beta-blockers, mineralocorticoid receptor antagonists, and renin-angiotensin system inhibitors). This evidence concerns the gene NR3C2 and hydrops fetalis.